Supplier Type
- Manufacturer
- Reagent
- Trader
- contract manufacturer
- custom synthesis
Supplier Region
- Hyderabad(27)
- Maharashtra(36)
- Gujarat(34)
- Tamil Nadu(3)
- New Delhi(5)
- Mumbai(46)
- Ahmedabad(14)
- Rajasthan(1)
- Andhra Pradesh(3)
- Delhi(11)
- Haryana(2)
- Vadodara(16)
- Uttar Pradesh(6)
- Telangana(4)
- Bangalore(3)
- Pune(3)
- Kolkata(3)
- Karnataka(8)
- Madhya Pradesh(2)
- Kerela(1)
- Beijing(2)
- Nagpur(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- Pure
- Powder 99%
- Potassium content 15.5 - 17.5
- NLT 98%
- NLT 95%
- NLT 90%
- NA
- more than 95%
- more than 90%
- minimum 96%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- lemon-lime grade (purity, 70%), a clear water-white ...
- High
- Greater than 99%
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- Cytidine 5'-Monophosphate Disodium Salt (C9H14N3Na2O8P) - High-purity pharmaceutical-grade
- Chemically Pure
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.98%
- 99.95%
- 99.91%
- 99.9%
- 99.86%
- 99.85%
- 99.83%
- 99.73%
- 99.60%
- 99.55 % MINIMUM
- 99.50%
- 99.5%
- 99.47%
- 99.42%
- 99.29%
- 99.23%
- 99.2%
- 99.05%
- 99.00%
- 99.0% e.e. Min
- 99.0%
- 99% Min
- >99%
- 99%
- 98+
- 98.85%
- 98.60%
- >98.5%
- 98.12%
- 98.00%
- 98%+
- 98%
- >98%
- 98 %
- 98
- 97-99%
- 97.57%
- 97.51%
- 97%
- >97%
- 97 %
- 96+1%
- 96.80%
- 96.40%
- 96.39%
- 96% Minimum
- 96% - 104%
- 96%
- 96 %
- 95.00%
- 95% - 98%
- 95%
- >95%
- 95 %
- 94.84%
- 94.25%
- 94.00%
- 92.55%
- >92%
- 90% min
- >90%
- 90%
- 90 % Above
- 80% min
- 75 %
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 10Gram
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1g
- 1gm
- 1000mg
- 5g
- 10g
- 25g
- 50g
- 100g
- 100gm
- 500g
- 500gm
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1and gm
- 1MT
- 95NLT %
- 250250 mg.
-
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, sodium salt (1:1), (4S)-
72517-83-0
-
[1,4'-Bipiperidine]-1'-carboxylic acid, (4S)-4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, hydrochloride (1:1)
207683-84-9
-
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, sodium salt (1:1), (4S)-
77987-01-0
-
4-Fluorobenzeneboronic acid
1765-93-1
-
Cyclopentanecarboxylic acid
3400-45-1
-
Naproxen sodium
26159-34-2
-
4-Aminopyrazolo[3,4-d]pyrimidine
2380-63-4
-
Disodium hydrogen phosphate dihydrate
10028-24-7
-
6-NITRO-1,3-BENZOXAZOLE
30693-53-9
-
((3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone
1103738-19-7
D-Amino acid oxidase 9000-88-8
D-alpha-Phenylglycine 875-74-1
(S)-(+)-2-Chlorophenylglycine methyl ester tartaric acid salt 141109-15-1
3-Nitrobenzenesulfonic acid sodium salt 127-68-4
4-Chloropyrrolo[2,3-d]-pyrimidine 3680-69-1
2-(Piperidin-4-yl)-1H-benzo[d]imidazole 38385-95-4
Tert-butyl 4-(1H-benzo(d)imidazol-2-yl)piperidine-1-carboxylate 953071-73-3
